Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIi pseudogene 9 (GTF2IP9) is a pseudogene located on human chromosome 9 and is related to the functional gene GTF2I, which encodes a transcription factor involved in gene regulation[7]. Pseudogenes like GTF2IP9 are typically nonfunctional, do not encode active proteins, and are not considered therapeutic targets, biomarkers, or disease-associated loci. GTF2IP9 has no well-established biological activity, clinical drug interactions, disease associations, or safety considerations. If your query pertains to drug target research, GTF2IP9 is not a valid entry; refer instead to “General transcription factor IIi (GTF2I)” as the true protein-coding gene target[7]. GTF2I (not GTF2IP9) is a gene encoding a transcription factor active in the regulation of cell growth, division, and cellular signaling, and is implicated in neurodevelopmental disorders such as Williams-Beuren syndrome[4][7]. Several pseudogenes—including GTF2IP9—exist for GTF2I, but these do not have the same functional properties, and their description should not be conflated with the actual gene or protein[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIi pseudogene 9 (GTF2IP9).